Shots:
- Roche has received the CE mark for its new Chest Pain Triage algorithm, developed with Universitätsklinikum Heidelberg as part of the navify algorithm suite to detect ACS in pts with chest pains; available in the EU, Middle East & Asia, with US availability planned for a later date
- Algorithm identifies non-cardiac chest pain by selecting appropriate ESC pathway (0/1, 0/2, or 0/3) based on blood sample timing, allowing accurate Rule-In/Rule-Out/Observe recommendations while reducing unnecessary hospitalizations
- Algorithm accelerates ACS treatment via rapid assessment of chest pain onset over 3hrs. before sampling, supports clinicians with medical dossier, & simplifies documentation with easy result transfer
Ref: Roche | Image: Roche
Related News:- Oak Hill Bio Enters an Exclusive Licensing Agreement with Roche for Rugonersen
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
